NCT00433940View on ClinicalTrials.gov

Immune Suppression Of Infants Treated With Steroids

CompletedOBSERVATIONAL
Enrollment

16

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

April 30, 2008

Study Completion Date

July 31, 2010

Conditions
Hemangioma
Interventions
DRUG

Prednisolone

Oral prednisolone sodium phosphate suspension administered in dosage of 15mg/5mL. Medication administered every morning at a starting daily dose of 2.5mg/kg.

Trial Locations (1)

53226

Children's Hospital of Wisconsin, Milwaukee

All Listed Sponsors
lead

Medical College of Wisconsin

OTHER

NCT00433940 - Immune Suppression Of Infants Treated With Steroids | Biotech Hunter | Biotech Hunter